Publikationen, an denen er mitarbeitet Josep Tabernero Caturla (3)

2023

  1. Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma

    Cancer Medicine, Vol. 12, Núm. 11, pp. 12071-12083

2017

  1. Strategies to design clinical studies to identify predictive biomarkers in cancer research

    Cancer Treatment Reviews, Vol. 53, pp. 79-97

2013

  1. The targeted therapy revolution in neuroendocrine tumors: In search of biomarkers for patient selection and response evaluation

    Cancer and Metastasis Reviews, Vol. 32, Núm. 3-4, pp. 465-477